Pezold Bros. v. City of Louisville

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• holding that disclosing a 7% mortality rate from the treatment group but not disclosing that there were zero deaths from the control group mislead investors about the safety of the tested medical device
• holding that disclosing a 7% mortality rate from the treatment group but not disclosing that there were zero deaths from the control group mislead investors about the safety of the tested medical device
• FDA approval statements made on conference calls and in press releases not actionable under PSLRA safe harbor because of publicly filed docs that contradicted plaintiff’s allegations
• alleged omissions were not actionable where public “[d]ocu-ments submitted by Defendants ... contradicted] the Complaint and show[ed] that the Company did disclose” the information allegedly omitted
• \Pharmaceutical companies need not disclose 'isolated reports of illnesses suffered by users.' \

Source: CourtListener parenthetical corpus (CC0).